India’s Torrent Pharma says nothing to disclose on Cipla stake buy report

India's Torrent Pharmaceuticals on Friday said it has no information requiring disclosure under listing regulations, after the Economic Times reported that it was in talks to buyout the stake of rival Cipla's top shareholders. Torrent said it "did not comment on speculative reports in the absence of verified data," and that it was not in a position to comment on the movement in its share price. Torrent Pharma is interested in buying out top shareholder Hamied family's 33.47% stake in Cipla and is trying to put together financing for the purchase, ET reported.